TrialCancer chemotherapy and pharmacology2013

Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab.

Matthew D Hellmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.